A238200 logo

BIFIDO Co., Ltd. Stock Price

KOSDAQ:A238200 Community·₩22.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

A238200 Share Price Performance

₩0
-3455.00 (-100.00%)
₩0
-3455.00 (-100.00%)
Price ₩0

A238200 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with very low risk.

2 Risks
0 Rewards

BIFIDO Co., Ltd. Key Details

₩19.7b

Revenue

₩12.2b

Cost of Revenue

₩7.5b

Gross Profit

₩7.7b

Other Expenses

-₩192.7m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-23.56
38.06%
-0.98%
26.1%
View Full Analysis

About A238200

Founded
1999
Employees
83
CEO
Myeongsoo Park
WebsiteView website
www.bifido.com

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.

Recent A238200 News & Updates

Analysis Article Oct 17

Some Confidence Is Lacking In BIFIDO Co., Ltd.'s (KOSDAQ:238200) P/S

BIFIDO Co., Ltd.'s ( KOSDAQ:238200 ) price-to-sales (or "P/S") ratio of 1.7x may not look like an appealing investment...

Recent updates

No updates